FDA guidance
Chapter 2 - Biologics
FDA guidance · Final · issued Dec 13, 2019
Key facts
| Title | Chapter 2 - Biologics |
|---|---|
| Status | Final |
| Issue date | Dec 13, 2019 |
| Center | Office of Inspections and Investigations |
| Issuing office | Center for Biologics Evaluation and Research |
| Communication type | Compliance Policy Guide (CPG) |
| Regulated product | Food & Beverages |
| Topics | Investigation & Enforcement |
| Open for comment | No |
At a glance
- None Product codes referenced
- None Recognized standards referenced
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA guidance documents
FDA guidance documents describe the agency's current thinking on regulatory topics. Drafts are issued for comment before a final version is published.
Source: U.S. Food and Drug Administration (FDA), Guidance Documents